DK138581B - Method for producing a virus subunit vaccine derived from an ether-sensitive virus. - Google Patents

Method for producing a virus subunit vaccine derived from an ether-sensitive virus.

Info

Publication number
DK138581B
DK138581B DK543974AA DK543974A DK138581B DK 138581 B DK138581 B DK 138581B DK 543974A A DK543974A A DK 543974AA DK 543974 A DK543974 A DK 543974A DK 138581 B DK138581 B DK 138581B
Authority
DK
Denmark
Prior art keywords
virus
ether
producing
subunit vaccine
sensitive
Prior art date
Application number
DK543974AA
Other languages
Danish (da)
Other versions
DK543974A (en
DK138581C (en
Inventor
Ian George Stephen Furminger
Margaret Irene Brady
Original Assignee
Flockhart & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flockhart & Co filed Critical Flockhart & Co
Publication of DK543974A publication Critical patent/DK543974A/da
Publication of DK138581B publication Critical patent/DK138581B/en
Application granted granted Critical
Publication of DK138581C publication Critical patent/DK138581C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A61K39/17—Newcastle disease virus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16151—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16251—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18151—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK543974AA 1973-10-18 1974-10-17 Method for producing a virus subunit vaccine derived from an ether-sensitive virus. DK138581B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB48685/73A GB1486557A (en) 1973-10-18 1973-10-18 Process for the preparation of pyrogen-free sub-unit vaccine

Publications (3)

Publication Number Publication Date
DK543974A DK543974A (en) 1975-06-16
DK138581B true DK138581B (en) 1978-10-02
DK138581C DK138581C (en) 1979-03-12

Family

ID=10449549

Family Applications (1)

Application Number Title Priority Date Filing Date
DK543974AA DK138581B (en) 1973-10-18 1974-10-17 Method for producing a virus subunit vaccine derived from an ether-sensitive virus.

Country Status (15)

Country Link
JP (1) JPS5082228A (en)
AT (1) AT334524B (en)
BE (1) BE821175A (en)
CA (1) CA1050886A (en)
CH (1) CH611518A5 (en)
DE (1) DE2449530C2 (en)
DK (1) DK138581B (en)
FR (1) FR2248054B1 (en)
GB (1) GB1486557A (en)
IE (1) IE40187B1 (en)
IL (1) IL45870A (en)
NL (1) NL181553C (en)
NO (1) NO142024C (en)
SE (1) SE426439B (en)
ZA (1) ZA746398B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK276380A (en) * 1979-07-09 1981-01-10 Univ Iowa State Res Found Inc PROCEDURE FOR THE PREPARATION OF A VACCINE AGAINST INFECTIOUS KVEG-RHINOTRACHEITIS
FR2470795A1 (en) * 1979-12-07 1981-06-12 Pasteur Institut PROCESS FOR THE PURIFICATION OF PARTICLES OF BIOLOGICAL ORIGIN, IN PARTICULAR OF THE SURFACE ANTIGEN OF HEPATITIS B VIRUS (AGHBS) AND THE PRODUCTS OBTAINED
FR2475572A1 (en) * 1980-02-11 1981-08-14 Pasteur Institut PROCESS FOR OBTAINING LIPID ENVELOPE VIRUS FRAGMENTS, PARTICULARLY ANTIGENS USED AS VACCINES, PRODUCTS OBTAINED AND APPLICATIONS
FR2483779A1 (en) 1980-06-05 1981-12-11 Synthelabo PROCESS FOR ISOLATING VIRAL GLYCOPROTETIC ANTIGENS AND APPLICATION THEREOF TO VACCINE PREPARATION
DE19938767C2 (en) * 1999-08-16 2002-10-24 Tad Pharma Gmbh subunit vaccines
CN1253207C (en) * 2000-10-02 2006-04-26 葛兰素史密丝克莱恩生物有限公司 Split enveloped virus preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3519400A (en) * 1967-01-25 1970-07-07 Atomic Energy Commission Method of centrifugal separation and recovery of chemical species utilizing a liquid medium

Also Published As

Publication number Publication date
DK543974A (en) 1975-06-16
FR2248054A1 (en) 1975-05-16
CH611518A5 (en) 1979-06-15
NL7413642A (en) 1975-04-22
SE7413113L (en) 1975-04-21
NO142024B (en) 1980-03-10
DE2449530C2 (en) 1985-08-08
NL181553C (en) 1987-09-16
DK138581C (en) 1979-03-12
GB1486557A (en) 1977-09-21
IE40187B1 (en) 1979-03-28
AU7444974A (en) 1976-04-29
CA1050886A (en) 1979-03-20
NL181553B (en) 1987-04-16
AT334524B (en) 1976-01-25
FR2248054B1 (en) 1978-07-28
IL45870A (en) 1978-03-10
DE2449530A1 (en) 1975-04-30
ATA835074A (en) 1976-05-15
BE821175A (en) 1975-04-17
NO142024C (en) 1980-06-18
JPS5082228A (en) 1975-07-03
IE40187L (en) 1975-04-18
SE426439B (en) 1983-01-24
NO743758L (en) 1975-05-12
ZA746398B (en) 1976-06-30
IL45870A0 (en) 1974-12-31

Similar Documents

Publication Publication Date Title
DK134032B (en) Method for producing a viable stable virus suspension.
DK136718B (en) Analogous process for the preparation of substituted hexahydro-dibenzo (b, d) -pyran-9-ones.
DK136719B (en) Analogous process for the preparation of substituted hexahydro-dibenzo (b, d) -pyrans.
DK135716B (en) Analogous process for the preparation of methyl 5-propylthio-2-benzimidazole carbamate.
DK145458C (en) PROCEDURE FOR REMOVING TI-PURPOSES FROM A KAOLINLER
DK135711B (en) Analogous process for the preparation of novel cardiac-active substituted phenoxyisopropanolamines.
DK136214C (en) PROCEDURE FOR PREPARING 2-AMINO-1,4-DIHYDROPYRIDINE DERIVATIVES
DK146535C (en) METHOD FOR PREPARING 3,4-DIHYDRO-2-METHYL-4-OXO-2H-1,2-BENZOTHIAZINE-1,1-DIOXIDE-3-CARBOXAMIDES
DK150860C (en) METHOD FOR PREPARING POLYLACTONES DERIVED FROM POLY-ALFA-HYDROXYACRYLIC ACID
DK139352B (en) Forming device for separating forms.
DK151993C (en) PROCEDURE FOR RECOVERING LEAD FROM USED LEAD CUMULATORS
DK138581B (en) Method for producing a virus subunit vaccine derived from an ether-sensitive virus.
DK139807B (en) Method for producing a recombinant influenza virus strain.
DK127370B (en) Method for removing a selected component from a gas stream.
DK146163C (en) PROCEDURE FOR RECOVERING USED PAPER
DK136529B (en) Analogous process for the preparation of benzofuran derivatives.
NL7501125A (en) EXTRACTION TUBE FOR POLYAMIDES.
DK135169B (en) Process for the preparation of a pure beta-trypsin derived from pigs.
DK143028C (en) METHOD FOR PREPARING N5-METHYLTETRAHYDRO-HOMOPHOLIC ACID FROM HOMOFOLIC ACID
DK129244B (en) Method for producing a typhoid vaccine.
DK146598C (en) METHOD FOR PREPARING 13BETA-ALKYL-4-GONEN-3,17-DIONE
DK135853B (en) Method for producing a killed vaccine against infectious coryza.
DK155326C (en) METHOD FOR PREPARING 1,4-BENZODIAZEPIN-2-ON DERIVATIVES
DK137931B (en) Method for producing a vaccine for immunizing poultry against Marek's disease.
DK128789B (en) Method for producing a severely attenuated live rubella virus vaccine.

Legal Events

Date Code Title Description
PBP Patent lapsed